The scope of work for the Core involves the establishment of a molecular epidemiology facility for the Cancer Center. This Core will be responsible for consulting with cancer members on molecular and genetic epidemiology and receiving, processing, barcode labeling and archiving blood, buccal, bone marrow, Guthrie blood spots, frozen and fixed tumor specimens. The Core will isolate DNA for genotyping studies and will coordinate their use with the other cores of the Cancer Center. In addition, the Core will carry out DNA adduct studies of tissue or peripheral mononuclear cells. Specifically the aims of the core are the following; To provide consultation to members concerning molecular epidemiology study design, incorporating appropriate biomarkers, advise on feasibility, sharing protocols, and questionnaires; To assist investigators carry out pilot studies. Provide field testing of protocols and biomarker assays for preliminary results for grant submissions; Specimen banking, tracking and database linkage. Provide processing, bar code labeling, storage, and customized tracking of biological specimens; cells, serum, blood, DNA, buccal cells, bone marrow, Guthrie cards, whole genome amplification (WGA) products; Special processing for genetic analyses. Carry out whole genome amplification and validation testing of buccal cells, Guthrie cards & other limited specimens and; Provide molecular analyses not available through other Cancer Center Cores. Specialized genotyping, methylation studies in fresh and paraffin embedded tissues, translocation breakpoint cloning/identification, DNA adduct measurements.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA082103-04
Application #
6694330
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-09-27
Project End
2007-01-31
Budget Start
Budget End
Support Year
4
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Brunner, Katja; John, Constance M; Phillips, Nancy J et al. (2018) Novel Campylobacter concisus lipooligosaccharide is a determinant of inflammatory potential and virulence. J Lipid Res 59:1893-1905
Felix, Janine F; Joubert, Bonnie R; Baccarelli, Andrea A et al. (2018) Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium. Int J Epidemiol 47:22-23u
Cobler, Lara; Zhang, Hui; Suri, Poojan et al. (2018) xCT inhibition sensitizes tumors to ?-radiation via glutathione reduction. Oncotarget 9:32280-32297
Li, Megan; Mulkey, Flora; Jiang, Chen et al. (2018) Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clin Cancer Res 24:4734-4744
Ryu, Jae Kyu; Rafalski, Victoria A; Meyer-Franke, Anke et al. (2018) Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat Immunol 19:1212-1223
Zhou, Yu; Zou, Hao; Yau, Christina et al. (2018) Discovery of internalizing antibodies to basal breast cancer cells. Protein Eng Des Sel 31:17-28
Tat, David; Kenfield, Stacey A; Cowan, Janet E et al. (2018) Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSUREā„¢). Prostate 78:32-39
Guydish, Joseph; Tajima, Barbara; Le, Thao et al. (2018) Do cigarette graphic warnings encourage smokers to attend a smoking cessation programme: a quasi-experimental study. Tob Control 27:43-49
Dvorak, Christopher C; Satwani, Prakash; Stieglitz, Elliot et al. (2018) Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Pediatr Blood Cancer 65:e27034
Fan, Qi Wen; Nicolaides, Theodore P; Weiss, William A (2018) Inhibiting 4EBP1 in Glioblastoma. Clin Cancer Res 24:14-21

Showing the most recent 10 out of 192 publications